03/12/2020

ImmunoPrecise Announces the Launch of PolyTope mAb Therapy   to Tackle Coronavirus Pandemic

ImmunoPrecise Announces Artificial Intelligence Collaboration With EVQLV To Accelerate Vaccine And Antibody Discovery For SARS-CoV-2 Coronavirus

02/20/20

ImmunoPrecise Launches Coronavirus Vaccine and Therapeutic Antibody Program

11/05/19

Talem Therapeutics accesses the OmniAb® platform from Ligand Pharmaceuticals

09/24/19

ImmunoPrecise’s Talem Therapeutics Enters into an LOI with AgonOx Pharma in the Advancement of Novel, Immuno-Oncology Therapeutics